Genetic polymorphisms in carcinogen detoxifying genes and risk of cervical cancer in Maharashtra, India: a case control study.

Polymorphism in GSTM1, GSTT1, GSTP1 and cervical cancer in Maharashtra

Authors

  • Kailas D Datkhile Krishna Institute of Medical Sciences
  • Madhavi N Patil Department of Molecular Biology & Genetics, Krishna Institute of Medical Sciences
  • Pratik P Durgawale Department of Molecular Biology & Genetics, Krishna Institute of Medical Sciences
  • Kalpita S Korabu Department of Molecular Biology & Genetics, Krishna Institute of Medical Sciences
  • Shreepad A Joshi Department of Molecular Biology & Genetics, Krishna Institute of Medical Sciences
  • Anand Gudur Department of Oncology, Krishna Institute of Medical Sciences
  • Rashmi A Gudur Department of Oncology, Krishna Institute of Medical Sciences
  • Satish V Kakade Department of Preventive & Social Medicine, Krishna Institute of Medical Sciences

DOI:

https://doi.org/10.7439/ijbr.v10i4.5105

Keywords:

Cervical Cancer, GSTM1, GSTT1, GSTP1, Genetic Polymorphism, PCR-RFLP

Abstract

Objectives: To explore the association of genetic polymorphisms in individual or combined genotypes of GSTM1, GSTT1 and GSTP1 with cervical cancer (CC) susceptibility in women from Maharashtra.

Methods: The polymorphisms in GSTM1 and GSTT1 were analyzed by polymerase chain reaction (PCR) and GSTP1 by polymerase chain reaction - Restriction Fragment Length Polymorphism (PCR-RFLP) in 350 CC cases and 400 healthy controls.

Results: In this study we found GSTM1 and GSTT1 as risk factors with significant association with null (-/-) genotypes of M1 and T1 with increasing the risk of CC by 1.41 and 1.46 folds respectively. GSTM1 (-/-) null genotype was prominent among cases (36.29%) indicating contributory risk factor for development of CC (OR=1.41; 95% CI: 1.03-1.91; p=0.02), GSTT1 null increases in CC cases (OR=1.46, 95% CI: 1.04-2.06; p=0.02). The combined analysis of GSTM1 (-/-) / GSTT1 (-/-) showed 2.27 folds higher risk of development of CC (OR=2.27, 95% CI: 1.25-4.09; p=0.005), whereas, combinations of GSTP1 genotype (A/G +G/G) of exon 5 with GSTM1 null, which showed 1.92 fold risk of CC (OR=1.92, 95% CI: 1.21-3.04; p=0.005) and combination of (C/T +T/T) genotype of GSTP1 exon 6 with GSTM1 (-/-) null did not show any association with development of CC (OR=0.81, 95% CI: 0.52-1.25; p=0.35). Triple combinations of GSTM1, T1 null and P1 (A/G or G/G) genotypes showed significant association (p=0.005) with a 3.04 times risk of developing CC.

Conclusions: This investigation affirms the conceivable interactions between GST polymorphisms and development of cervical cancer in rural population of south western Maharashtra from India.

Downloads

Download data is not yet available.

Downloads

Published

2019-04-28

Issue

Section

Original Research Articles

How to Cite

1.
Genetic polymorphisms in carcinogen detoxifying genes and risk of cervical cancer in Maharashtra, India: a case control study.: Polymorphism in GSTM1, GSTT1, GSTP1 and cervical cancer in Maharashtra. Int Jour of Biomed Res [Internet]. 2019 Apr. 28 [cited 2025 Mar. 12];10(4):e5105. Available from: https://ssjournals.co.in/index.php/ijbr/article/view/5105